106 results
DEF 14A
BTTX
Better Therapeutics Inc
27 Apr 22
Definitive proxy
12:37pm
RELATIONSHIPS AND RELATED PERSON TRANSACTIONS
AUDIT COMMITTEE REPORT
PROPOSAL 2: RATIFICATION OF THE SELECTION OF INDEPENDENT REGISTERED PUBLIC … on the board of directors of ChemoCentryx, Inc., where he serves on the audit committee, compensation committee, and nominating and governance
8-K
BTTX
Better Therapeutics Inc
24 Nov 21
Changes in Registrant's Certifying Accountant
9:00pm
.
On November 19, 2021, the Audit Committee of the Board of Directors (the “Audit Committee”) of Better Therapeutics, Inc., formerly known as Mountain Crest … ) through December 31, 2020 did not contain an adverse opinion or disclaimer of opinion, nor were they qualified or modified as to uncertainty, audit
10-K
2020 FY
BTTX
Better Therapeutics Inc
31 Mar 21
Annual report
12:00am
programs, among others. Dr. Milbourn is also the Director and Chair of the Audit Committee of the Xanthus Fund at Oppenheimer. Dr. Milbourn obtained …
The Board has a standing audit committee and a standing compensation committee. Each committee has a charter, in the form previously filed
8-K
EX-16.1
xn71lf
3 Nov 21
Unaudited Pro Forma Condensed Combined Financial Statements
5:26pm
S-8
EX-23.1
oqn4dxcc
11 Jan 22
Registration of securities for employees
6:07am
8-K
tty1d30dot1 qd
22 Nov 21
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
9:44pm
8-K
EX-99.1
h9rxbv 8fz9l7e2
19 Jan 21
Mountain Crest Acquisition Corp. Ii
5:23pm
424B3
khuy0nl bbleh
14 Jan 22
Prospectus supplement
5:14pm
8-K/A
kugfer
14 Jan 22
Changes in Registrant's Certifying Accountant
5:11pm
8-K
mosb zy6mf
3 Nov 21
Unaudited Pro Forma Condensed Combined Financial Statements
5:26pm
8-K
EX-10.6
sueydez75h30exq4yp3w
3 Nov 21
Unaudited Pro Forma Condensed Combined Financial Statements
5:26pm
S-1
mk546snmrofx7jaw4
21 Dec 20
IPO registration
5:23pm
424B4
lqbbi8
11 Jan 21
Prospectus supplement with pricing info
4:18pm
DRS
xd5 xtsdhjb
18 Nov 20
Draft registration statement
12:00am
S-4
EX-23.1
ui0v4s895zpsm14t y7
23 Apr 21
Registration of securities issued in business combination transactions
5:24pm